Woodard & Company Asset Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Woodard & Company Asset Management Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,200	Closed	-$815K	–	100
2021 Q2	$815K	Buy	12,200 +917	+8%	+$59.8K	0.49%	38
2021 Q1	$712K	Buy	11,283 +1,010	+10%	+$62.8K	0.45%	40
2020 Q4	$637K	Buy	10,273 +786	+8%	+$48.3K	0.39%	36
2020 Q3	$577K	Buy	9,487 +562	+6%	+$33.8K	0.38%	35
2020 Q2	$525K	Buy	8,925 +802	+10%	+$48K	0.35%	39
2020 Q1	$453K	Buy	+8,123	New	+$496K	0.33%	38
2018 Q4	–	Sell	-300	Closed	-$18K	–	50
2018 Q3	$18K	Hold	300	–	–	0.02%	131
2018 Q2	$16.6K	Hold	300	–	–	0.02%	126
2018 Q1	$19K	Hold	300	–	–	0.02%	121
2017 Q4	$18K	Buy	+300	New	+$18.8K	0.02%	143

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Woodard & Company Asset Management Group's BMY Position: Q3 2021 in Review

Woodard & Company Asset Management Group sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 12,200 shares — an estimated $815K sold.

Woodard & Company Asset Management Group first reported a position in BMY in Q4 2017 and held it in 10 quarters. The position peaked at $815K in Q2 2021. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

Woodard & Company Asset Management Group reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
Woodard & Company Asset Management Group sold 12,200 Bristol-Myers Squibb shares in Q3 2021, an estimated $815K.
Woodard & Company Asset Management Group first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 10 quarters.
Woodard & Company Asset Management Group's Bristol-Myers Squibb position peaked at $815K in Q2 2021.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Woodard & Company Asset Management Group's 13F filing for Q3 2021, filed 29 Oct 2021.